Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Actilitio vs Theralite in Healthy Subjects
NCT06861842Phase 4Active, not recruiting
- Sponsor
- CAIMED
- Start
- Jun 2024
- Primary completion
- Apr 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium carbonate in bipolar disorder (BD), sponsored by CAIMED. Started Jun 2024; status: active, not recruiting.
02
Drugs
lithium carbonate
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT06861842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06861842.